Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Scheer

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|September 10, 2009
A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2Herman S Gill, Jeff N Tinianow, Annie Ogasawara, et al.
The Journal of Biological Chemistry|October 27, 2009
X chromosome-linked inhibitor of apoptosis regulates cell death induction by proapoptotic receptor agonistsEugene Varfolomeev, Bruno Alicke, J Michael Elliott, et al.
Molecular Pharmaceutics|November 17, 2018
In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery ApproachesKelly M Loyet, Philip E Hass, Wendy N Sandoval, et al.
Plos One|June 29, 2019
Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eyeWhitney Shatz, Philip E Hass, Nikhil Peer, et al.
Molecular Pharmaceutics|June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched FabWhitney Shatz, Philip E Hass, Mary Mathieu, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Mabs|August 31, 2017
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eyeDevin Tesar, Jacob Luoma, Emily A Wyatt, et al.
The Journal of Biological Chemistry|May 7, 2010
Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signalingJanet Jackman, Yongmei Chen, Arthur Huang, et al.
Cancer Research|September 18, 2014
Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cellsTeemu T Junttila, Ji Li, Jennifer Johnston, et al.
The Journal of Biological Chemistry|July 25, 2013
Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokinesChristoph Spiess, Jack Bevers, Janet Jackman, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|September 10, 2009
A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2Herman S Gill, Jeff N Tinianow, Annie Ogasawara, et al.
The Journal of Biological Chemistry|October 27, 2009
X chromosome-linked inhibitor of apoptosis regulates cell death induction by proapoptotic receptor agonistsEugene Varfolomeev, Bruno Alicke, J Michael Elliott, et al.
Molecular Pharmaceutics|November 17, 2018
In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery ApproachesKelly M Loyet, Philip E Hass, Wendy N Sandoval, et al.
Plos One|June 29, 2019
Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eyeWhitney Shatz, Philip E Hass, Nikhil Peer, et al.
Molecular Pharmaceutics|June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched FabWhitney Shatz, Philip E Hass, Mary Mathieu, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Mabs|August 31, 2017
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eyeDevin Tesar, Jacob Luoma, Emily A Wyatt, et al.
The Journal of Biological Chemistry|May 7, 2010
Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signalingJanet Jackman, Yongmei Chen, Arthur Huang, et al.
Cancer Research|September 18, 2014
Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cellsTeemu T Junttila, Ji Li, Jennifer Johnston, et al.
The Journal of Biological Chemistry|July 25, 2013
Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokinesChristoph Spiess, Jack Bevers, Janet Jackman, et al.
Pageof 4